Immune Monitoring
Immune Monitoring
批准号:
7728800
负责人:
PHILIP O. LIVINGSTON
金额:
$12.5万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-07-01 至 2010-06-30
关键词:
AntibodiesAntibody FormationBiological AssayCancer Vaccine Related DevelopmentCancer VaccinesDevelopmentFacility Construction Funding CategoryImmuneImmunityImmunologic MonitoringIndividualInterventionModificationMonitorMonoclonal AntibodiesPeptidesPhenotypeProcessRadiolabeledReagentSeriesSerologicalSpecificityT-LymphocyteTestingTimeVaccinationVaccinesbasedesignexperienceimmunogenicityprogramsradiotracerresponse
中文摘要
免疫监测核心将为该计划项目中的所有四个项目提供支持。这四个
英文摘要
The Immune Monitoring Core will provide support for all four projects in this Program Project. The four
Projects involve treatment with monoclonal antibodies (mAb) or tumor vaccines. MAb (humanized or
chimerized) or radiolabeled mAb efficacy may be diminished by development of antibodies against the mAb
(HAHA). Some types of HAHA may be avoided by modifications in mAb design, requiring sensitive assays
for identifying and determining the precise specificity of the HAHA. Cancer vaccine development must be
based on assays of immunogenicity that can guide the process of vaccine construction. In both cases,
maximal benefit will result if these assays are standardized and are performed by a centralized, dedicated
facility, permitting comparison between Projects and overtime. While serological assays are sufficient for
monitoring mAb studies in Projects 1 and 2, assays of T-lymphocyte immunity will also be required and will
be the main focus for the vaccination studies in Aims 3 and 4. The emphasis is on providing assay
continuity within and between the projects and between these projects and our previous experience. A
series of standardized assays will be used to provide the P.l.s of the individual Projects with a firm basis for
selecting monoclonal antibodies (mAbs) or vaccines for further study.
The Specific Aims are:
Aim 1: Utilize standardized serologic assays for quantitating the antibody response to immune interventions
in this Program Project, and determine the effector functions of these antibodies.
Aim 2: Utilize a series of standardized assays to quantitate the T-cell response after vaccination and to
determine the phenotype and effector functions of the responding T-cells. Identify the peptides recognized
by these T-cells.
Aim 3: Utilize these centralized, standardized assays to provide continuity within and between the Projects
over time, and between these Projects and our previous experience.
Aim 4: Continue to test and standardize new reagents or assays as they become available.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Large Scale Synthesis of the Next Generation Synthetic Saponin Adjuvant TiterQuil
-
批准号:8779665
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2014
-
负责人:PHILIP O. LIVINGSTON
-
依托单位:
Human Monoclonal Antibodies from Immunized Patient Lymphocytes
-
批准号:7405003
-
项目类别:
-
资助金额:$19.78万
-
财政年份:2008
-
负责人:PHILIP O. LIVINGSTON
-
依托单位:
Characterization of human antibodies to sialyl-Lewis A (sLeA) derived from patien
-
批准号:7801424
-
项目类别:
-
资助金额:$53.57万
-
财政年份:2008
-
负责人:PHILIP O. LIVINGSTON
-
依托单位:
Pilot trial with a tetravalent conjugate vaccine against small cell lung cancer
-
批准号:7325719
-
项目类别:
-
资助金额:$20.18万
-
财政年份:2007
-
负责人:PHILIP O. LIVINGSTON
-
依托单位:
Development of Antibody and T-Cell Inducing Vaccines
-
批准号:6952121
-
项目类别:
-
资助金额:$28.35万
-
财政年份:2005
-
负责人:PHILIP O. LIVINGSTON
-
依托单位:
Regulation by Immune Response to Vaccine by Botanicals
-
批准号:6946042
-
项目类别:
-
资助金额:$29.29万
-
财政年份:2005
-
负责人:PHILIP O. LIVINGSTON
-
依托单位:
GLYCOLIPID AND PROTEIN VACCINES AGAINST CANCER
-
批准号:6563801
-
项目类别:
-
资助金额:$29.18万
-
财政年份:2002
-
负责人:PHILIP O. LIVINGSTON
-
依托单位:
GLYCOLIPID AND PROTEIN VACCINES AGAINST CANCER
-
批准号:6423086
-
项目类别:
-
资助金额:$29.18万
-
财政年份:2001
-
负责人:PHILIP O. LIVINGSTON
-
依托单位:
CLINICAL TRIALS WITH ACTIVE AND PASSIVE IMMUNOTHERAPY AGAINST OVARIAN CANCER
-
批准号:6334957
-
项目类别:
-
资助金额:$26.78万
-
财政年份:2000
-
负责人:PHILIP O. LIVINGSTON
-
依托单位:
GLYCOLIPID AND PROTEIN VACCINES AGAINST CANCER
-
批准号:6300242
-
项目类别:
-
资助金额:$29.18万
-
财政年份:2000
-
负责人:PHILIP O. LIVINGSTON
-
依托单位:
DEVELOPMENT OF CANCER VACCINES
-
批准号:6102118
-
项目类别:
-
资助金额:$28.01万
-
财政年份:1999
-
负责人:PHILIP O. LIVINGSTON
-
依托单位:
CLINICAL TRIALS WITH ACTIVE AND PASSIVE IMMUNOTHERAPY AGAINST OVARIAN CANCER
-
批准号:6203171
-
项目类别:
-
资助金额:$26.78万
-
财政年份:1999
-
负责人:PHILIP O. LIVINGSTON
-
依托单位:
DEVELOPMENT OF CANCER VACCINES
-
批准号:6269152
-
项目类别:
-
资助金额:$26.93万
-
财政年份:1998
-
负责人:PHILIP O. LIVINGSTON
-
依托单位:
CLINICAL TRIALS WITH ACTIVE AND PASSIVE IMMUNOTHERAPY AGAINST OVARIAN CANCER
-
批准号:6102612
-
项目类别:
-
资助金额:$26.78万
-
财政年份:1998
-
负责人:PHILIP O. LIVINGSTON
-
依托单位:
DEVELOPMENT OF CANCER VACCINES
-
批准号:6236654
-
项目类别:
-
资助金额:$25.13万
-
财政年份:1997
-
负责人:PHILIP O. LIVINGSTON
-
依托单位:
CONSTRUCTION OF VACCINES AGAINST BREAST CANCER
-
批准号:2102174
-
项目类别:
-
资助金额:$19.46万
-
财政年份:1994
-
负责人:PHILIP O. LIVINGSTON
-
依托单位:
CLINICAL TRIALS WITH A POLYVALENT BREAST CANCER VACCINE
-
批准号:2008350
-
项目类别:
-
资助金额:$28.97万
-
财政年份:1994
-
负责人:PHILIP O. LIVINGSTON
-
依托单位:
CLINICAL TRIALS WITH A POLYVALENT BREAST CANCER VACCINE
-
批准号:2882392
-
项目类别:
-
资助金额:$30.59万
-
财政年份:1994
-
负责人:PHILIP O. LIVINGSTON
-
依托单位:
CONSTRUCTION OF VACCINES AGAINST BREAST CANCER
-
批准号:2102176
-
项目类别:
-
资助金额:$20.48万
-
财政年份:1994
-
负责人:PHILIP O. LIVINGSTON
-
依托单位:
CONSTRUCTION OF VACCINES AGAINST BREAST CANCER
-
批准号:2102175
-
项目类别:
-
资助金额:$19.92万
-
财政年份:1994
-
负责人:PHILIP O. LIVINGSTON
-
依托单位:
海外基金